Relationship between histopathological findings and RAI in non-papillary follicular cell–derived thyroid carcinoma
Journal of the Endocrine Society · 03.06.2026 · 10 (7)
DOI: 10.1210/jendso/bvag120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 21.05.2026. Verfasst von Haruhiko Yamazaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama City, Kanagawa 232-0024, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Context
Detailed studies considering the distinct types of non-papillary follicular cell–derived thyroid carcinoma in terms of radioactive iodine (RAI) avidity are limited.
Objective
This study aimed to investigate clinicopathological characteristics, relationship between histopathological findings, including solid/trabecular/insular (STI) components and RAI treatment (RAIT), in patients with non-papillary follicular cell–derived thyroid carcinoma.
Methods
This study included 114 patients with non-papillary follicular cell–derived thyroid carcinoma who underwent first RAIT between January 2005 and August 2025.
Results
Of the 114 patients, 5 (4%) were minimally invasive follicular thyroid carcinoma (MI-FTC), 41 (36%) were encapsulated angio-invasive FTC (EA-FTC), 23 (20%) were widely invasive FTC (WI-FTC), 22 (19%) were differentiated high-grade thyroid carcinoma (DHGTC), 21 (18%) were poorly differentiated thyroid carcinoma (PDTC), and 2 (2%) were others, respectively. The median percentages of STI component was 40% (range, 0%-10%) in all patients, 5% (range, 0%-50%) in MI-FTC, 30% (range, 0%-100%) in EA-FTC, 30% (range, 0%-100%) in WI-FTC, 28% (range, 5%-70%) in DHGTC, and 70% (range, 50%-100%) in PDTC, respectively. Among the 114 patients, the rate of RAI avidity was 60% (95% CI, 49%-71%) (47/78) in lung, 89% (95% CI, 79%-96%) (59/66) was in bone, 100% (13/13) in lymph node, and 100% (3/3) in other sites, respectively.
Conclusion
RAI avidity was relatively high in non-papillary follicular cell–derived thyroid carcinoma, regardless of the histological type and percentage of STI components.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama City, Kanagawa 232-0024, Japan.
- Department of Surgery, Ito Hospital, Tokyo 150-8308, Japan.
- Department of Pathology, Ito Hospital, Tokyo 150-8308, Japan.
- Department of Surgery, Yokohama City University School of Medicine, Yokohama City, Kanagawa 236-0004, Japan.
ORCID-Profile: Haruhiko Yamazaki, Kiminori Sugino
Zitieren
APA
Yamazaki, H., Sugino, K., Katoh, R., Kawaida, M., Matsuzu, K., Kitagawa, W., Saito, A., & Ito, K. (2026). Relationship between histopathological findings and RAI in non-papillary follicular cell–derived thyroid carcinoma. Journal of the Endocrine Society, 10(7). https://doi.org/10.1210/jendso/bvag120
Vancouver
Yamazaki H, Sugino K, Katoh R, Kawaida M, Matsuzu K, Kitagawa W, et al. Relationship between histopathological findings and RAI in non-papillary follicular cell–derived thyroid carcinoma. Journal of the Endocrine Society. 2026;10(7). doi:10.1210/jendso/bvag120
BibTeX
@article{Yamazaki2026,
author = {Yamazaki, Haruhiko and Sugino, Kiminori and Katoh, Ryohei and Kawaida, Miho and Matsuzu, Kenichi and Kitagawa, Wataru and Saito, Aya and Ito, Koichi},
title = {Relationship between histopathological findings and RAI in non-papillary follicular cell–derived thyroid carcinoma},
journal = {Journal of the Endocrine Society},
year = {2026},
volume = {10},
number = {7},
doi = {10.1210/jendso/bvag120}
}
EUVIMED